Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: Clinical experience with a rare entity

Cancer

Volumn 118, Issue 3, 2012, Pages 612-619

  Gorshtein, Alexander ^a   Gross, David J ^b   Barak, Dganit ^b   Strenov, Yulia ^a   Refaeli, Yael ^a   Shimon, Ilan ^a,c   Grozinsky Glasberg, Simona ^a,c  

^a RABIN MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

carcinoid; diffuse idiopathic pulmonary neuroendocrine cell hyperplasia; neuroendocrine; somatostatin analogs; tumorlets

Indexed keywords

ANGIOPEPTIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ADULT; AGED; ARTICLE; CARCINOID; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DIARRHEA; DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISRAEL; LUNG DISEASE; LUNG NEUROENDOCRINE TUMOR; LUNG TUMOR; MULTIPLE PULMONARY NODULES; NEUROENDOCRINE DISEASE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORACOTOMY; TUMOR VOLUME; WELLBEING; WHEEZING;

ADULT; AGED; CARCINOID TUMOR; FEMALE; HUMANS; HYPERPLASIA; LUNG NEOPLASMS; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NEUROENDOCRINE CELLS; NEUROENDOCRINE TUMORS; PRECANCEROUS CONDITIONS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 80755155450     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26200     Document Type: Article

References (31)

1. Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS,. Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. Radiographics. 2006; 26: 41-57.
2. Aguayo SM, Miller YE, Waldron JA Jr, et al. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med. 1992; 327: 1285-1288.
3. Gosney JR,. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia as a precursor to pulmonary neuroendocrine tumors. Chest. 2004; 125 (5 suppl): 108S-108S.
4. Beasley MB, Brambilla E, Travis WD,. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005; 40: 90-97.
5. Aubry MC, Thomas CF Jr, Jett JR, Swensen SJ, Myers JL,. Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens: analysis of 28 patients. Chest. 2007; 131: 1635-1643.
6. Miller RR, Muller NL,. Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol. 1995; 18: 653-658.
7. Ruffini E, Bongiovanni M, Cavallo A, et al. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms. Eur J Cardiothorac Surg. 2004; 26: 165-172.
8. Hyatt RE, Cowl CT, Bjoraker JA, Scanlon PD,. Conditions associated with an abnormal nonspecific pattern of pulmonary function tests. Chest. 2009; 135: 419-424.
9. Rindi G, de Herder WW, O'Toole D, Wiedenmann B,. Consensus guidelines for the management of patients with digestive neuroendocrine tumors: the second event and some final considerations. Neuroendocrinology. 2008; 87: 5-7.
10. Davies SJ, Gosney JR, Hansell DM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax. 2007; 62: 249-252.
11. Churg A, Warnock ML,. Pulmonary tumorlet. A form of peripheral carcinoid Cancer. 1976; 37: 1469-1477.
12. Miller MA, Mark GJ, Kanarek D,. Multiple peripheral pulmonary carcinoids and tumorlets of carcinoid type, with restrictive and obstructive lung disease. Am J Med. 1978; 65: 373-378.
13. Armas OA, White DA, Erlandson RA, Rosai J,. Diffuse idiopathic pulmonary neuroendocrine cell proliferation presenting as interstitial lung disease. Am J Surg Pathol. 1995; 19: 963-970.
14. Lee JS, Brown KK, Cool C, Lynch DA,. Diffuse pulmonary neuroendocrine cell hyperplasia: radiologic and clinical features. J Comput Assist Tomogr. 2002; 26: 180-184.
15. Sheerin N, Harrison NK, Sheppard MN, Hansell DM, Yacoub M, Clark TJ,. Obliterative bronchiolitis caused by multiple tumourlets and microcarcinoids successfully treated by single lung transplantation. Thorax. 1995; 50: 207-209.
16. Skinner C, Ewen SW,. Carcinoid lung: diffuse pulmonary infiltration by a multifocal bronchial carcinoid. Thorax. 1976; 31: 212-219.
17. Adams H, Brack T, Kestenholz P, Vogt P, Steinert HC, Russi EW,. Diffuse idiopathic neuroendocrine cell hyperplasia causing severe airway obstruction in a patient with a carcinoid tumor. Respiration. 2006; 73: 690-693.
18. Brown MJ, English J, Muller NL,. Bronchiolitis obliterans due to neuroendocrine hyperplasia: high-resolution CT-pathologic correlation. AJR Am J Roentgenol. 1997; 168: 1561-1562.
19. Cohen AJ, King TE Jr, Gilman LB, Magill-Solc C, Miller YE,. High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells. Am J Respir Crit Care Med. 1998; 158 (5 pt 1): 1593-1599.
20. Ge Y, Eltorky MA, Ernst RD, Castro CY,. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Ann Diagn Pathol. 2007; 11: 122-126.
21. Johney EC, Pfannschmidt J, Rieker RJ, Schnabel PA, Mechtersheimer G, Dienemann H,. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and a typical carcinoid tumor. J Thorac Cardiovasc Surg. 2006; 131: 1207-1208.
22. Papla B, Zielinski M, Kuzdzal J, Harazda M,. Hyperplasia of endocrine cells, tumorlets and atypical carcinoid of the lung-a case report. Pol J Pathol. 2004; 55: 31-33.
23. Warth A, Herpel E, Schmahl A, Storz K, Schnabel PA,. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in association with an adenocarcinoma: a case report [serial online]. J Med Case Reports. 2008; 2: 21.
24. Cameron CM, Roberts F, Connell J, Sproule MW,. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an unusual cause of cyclical ectopic adrenocorticotrophic syndrome. Br J Radiol. 2011; 84: e14-e17.
25. Fessler MB, Cool CD, Miller YE, Schwarz MI, Brown KK,. Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells in a patient with acromegaly. Respirology. 2004; 9: 274-277.
26. Pinchot SN, Holen K, Sippel RS, Chen H,. Carcinoid tumors. Oncologist. 2008; 13: 1255-1269.
27. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y,. The new World Health Organization classification of lung tumours. Eur Respir J. 2001; 18: 1059-1068.
28. Swigris J, Ghamande S, Rice T, Farver C,. Diffuse idiopathic neuroendocrine cell hyperplasia. an interstitial lung disease with airway obstruction. J Bronch. 2005; 12: 62-64.
29. Granberg D, Eriksson B, Wilander E, et al. Experience in treatment of metastatic pulmonary carcinoid tumors. Ann Oncol. 2001; 12: 1383-1391.
30. Saltz L, Trochanowski B, Buckley M, et al. Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer. 1993; 72: 244-248.
31. Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM,. Bronchopulmonary neuroendocrine tumors. Cancer. 2008; 113: 5-21.